Fortress Biotech, Inc. (NASDAQ:FBIO) Given Consensus Recommendation of Buy by Analysts

Fortress Biotech, Inc. (NASDAQ:FBIO – Get Free Report) has been assigned a consensus recommendation of “Buy” from the five brokerages that are presently covering the stock, MarketBeat reports. Five equities research analysts have rated the stock with a buy recommendation. The average 1-year price target among analysts that have issued a report on the stock […]

Related Keywords

Roth Mkm ,Fortress Biotech Company Profile ,Envestnet Asset Management Inc ,Sigma Securities ,Fortress Biotech Inc ,Advisor Group Holdings Inc ,Nasdaq ,Wells Fargo Company ,Alliance Global Partners ,Fortress Biotech ,Get Free Report ,Global Partners ,Group Holdings ,Envestnet Asset Management ,Get Free ,Fortress Biotech Daily ,